Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 204

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Familial hypercholesterolaemia: A model of care for Australasia

Open access
Watts, Gerald F., Sullivan, David R, Poplawski, Nicola, van Bockxmeer, Frank, Hamilton-Craig, Ian, Clifton, Peter M., O’Brien, Richard, Bishop, Warrick, George, Peter, Barter, Phillip J., Bates, Timothy, Burnett, John R., Coakley, John, Davidson, Patricia, Emery, Jon, Martin, Andrew, Farid, Waleed, Freeman, Lucinda, Geelhoed, Elizabeth, Juniper, Amanda, Kidd, Alexa, Kostner, Karam, Krass, Ines, Livingston, Michael, Maxwell, Suzy, O’Leary, Peter, Owaimrin, Amal, Redgrave, Trevor G., Reid, Nicola, Southwell, Lynda, Suthers, Graeme, Tonkin, Andrew, Towler, Simon, Trent, Ronald · 2011 · Atherosclerosis Supplements

Abstract

Familial hypercholesterolaemia (FH) is a dominantly inherited disorder present from birth that causes marked elevation in plasma cholesterol and premature coronary heart disease. There are at least 45,000 people with FH in Australia and New Zealand, but the vast majority remains undetected and those diagnosed with the condition are inadequately treated. To bridge this major gap in coronary prevention the FH Australasia Network (Australian Atherosclerosis Society) has developed a consensus model of care (MoC) for FH. The MoC is based on clinical experience, expert opinion, published evidence and consultations with a wide spectrum of stakeholders, and has been developed for use primarily by specialist centres intending starting a clinical service for FH. This MoC aims to provide a standardised, high-quality and cost-effective system of care that is likely to have the highest impact on patient outcomes. The MoC for FH is presented as a series of recommendations and algorithms focusing on the standards required for the detection, diagnosis, assessment and management of FH in adults and children. The process involved in cascade screening and risk notification, the backbone for detecting new cases of FH, is detailed. Guidance on treatment is based on risk stratifying patients, management of non-cholesterol risk factors, safe and effective use of statins, and a rational approach to follow-up of patients. Clinical and laboratory recommendations are given for genetic testing. An integrative system for providing best clinical care is described. This MoC for FH is not prescriptive and needs to be complemented by good clinical judgment and adjusted for local needs and resources. After initial implementation, the MoC will require critical evaluation, development and appropriate modification.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosissup.2011.06.001

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 204

Metadata

Authors
Watts, G. F., Sullivan, D. R., Poplawski, N., van Bockxmeer, F., Hamilton-Craig, I., Clifton, P. M., O’Brien, R., Bishop, W., George, P., Barter, P. J., Bates, T., Burnett, J. R., Coakley, J., Davidson, P., Emery, J., Martin, A., Farid, W., Freeman, L., Geelhoed, E., Juniper, A., Kidd, A., Kostner, K., Krass, I., Livingston, M., Maxwell, S., O’Leary, P., Owaimrin, A., Redgrave, T. G., Reid, N., Southwell, L., Suthers, G., Tonkin, A., Towler, S., & Trent, R.
Venue
Atherosclerosis Supplements
Publisher
Elsevier BV
Published
2011-10
Volume
12
Issue
2
Pages
221-263
ISSN
1567-5688 (ISSN-L)
OpenAlex
W2069925045
Cited by
204
References
34
FWCI
18.38
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Familial hypercholesterolaemia: A model of care for Australasia. https://app.cochat.ai/papers/10.1016/j.atherosclerosissup.2011.06.001
The paper
Watts, G. F., Sullivan, D. R., Poplawski, N., van Bockxmeer, F., Hamilton-Craig, I., Clifton, P. M., O’Brien, R., Bishop, W., George, P., Barter, P. J., Bates, T., Burnett, J. R., Coakley, J., Davidson, P., Emery, J., Martin, A., Farid, W., Freeman, L., Geelhoed, E., . . . Trent, R. (2011). Familial hypercholesterolaemia: A model of care for Australasia. Atherosclerosis Supplements. https://doi.org/10.1016/j.atherosclerosissup.2011.06.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.